NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Vantage Biosciences

Vantage Biosciences

Private
LondonHealthcare & Life Scienceshttps://vantage-biosciences.com/

Last Round

Seed

Jul 19, 2023

Company Overview

Vantage Biosciences is a biotechnology company that develops novel oral therapies for inflammatory conditions, including diabetic retinopathy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverydiabetic retinopathysmall-molecule inhibitorclinical-stage biotechoral therapyAOC-3 inhibitorNPDRnon-proliferative diabetic retinopathyclinical trialsneurovascular inflammationophthalmologydrug developmentbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vantage Biosciences Comparables

Compare Vantage Biosciences with similar companies based on industry and business-model similarity.

Vantage Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Breye Therapeutics
87%
Opus Genetics
79%
Boehringer Ingelheim
72%
View all Comparables

Vantage Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 19, 2023
View all Funding Rounds

Vantage Biosciences Investors

Notable investors and investment history

Vantage Biosciences investors
InvestorRounds
ALSA VenturesSeed
View all Investors

Vantage Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vantage Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vantage Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range6
Year Founded2023
Last FundingJul 19, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.